Vanguard Personalized Indexing Management
TNGX icon

Vanguard Personalized Indexing Management’s Tango Therapeutics TNGX Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$632K Sell
20,223
-3,294
-14% -$81.4K 0.01% 1266
2026
Q1 		$492K Buy
23,517
+3,115
+15% +$43.4K ﹤0.01% 1325
2025
Q4 		$181K Buy
20,402
+189
+0.9% +$1.63K ﹤0.01% 1739
2025
Q3 		$170K Sell
20,213
-156
-0.8% -$1.06K ﹤0.01% 1741
2025
Q2 		$104K Buy
20,369
+9,737
+92% +$24.1K ﹤0.01% 1729
2025
Q1 		$14.6K Buy
+10,632
New +$26.1K ﹤0.01% 1803

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Vanguard Personalized Indexing Management's TNGX Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Tango Therapeutics (TNGX) stake by 14% in Q2 2026, selling an estimated $81.4K and leaving 20,223 shares worth $632K. The position accounts for 0.01% of the portfolio, ranked #1266.

Vanguard Personalized Indexing Management first reported a position in TNGX in Q1 2025 and has held it in 6 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Vanguard Personalized Indexing Management held 20,223 shares of Tango Therapeutics worth $632K as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 3,294 Tango Therapeutics shares in Q2 2026, an estimated $81.4K.
  • Tango Therapeutics made up 0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1266 holding.
  • Vanguard Personalized Indexing Management first reported a position in Tango Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.